• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种针对淋巴瘤医学研究的新方法:基于索赔算法识别新发病例的研究验证

A novel approach for medical research on lymphomas: A study validation of claims-based algorithms to identify incident cases.

作者信息

Conte Cécile, Palmaro Aurore, Grosclaude Pascale, Daubisse-Marliac Laetitia, Despas Fabien, Lapeyre-Mestre Maryse

机构信息

LEASP-UMR 1027, Inserm-University of Toulouse Medical and Clinical Pharmacology Unit CIC 1436, Toulouse University Hospital Claudius Regaud Institute, IUCT-O, Tarn Cancer Registry, Toulouse, France.

出版信息

Medicine (Baltimore). 2018 Jan;97(2):e9418. doi: 10.1097/MD.0000000000009418.

DOI:10.1097/MD.0000000000009418
PMID:29480830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5943849/
Abstract

The use of claims database to study lymphomas in real-life conditions is a crucial issue in the future. In this way, it is essential to develop validated algorithms for the identification of lymphomas in these databases. The aim of this study was to assess the validity of diagnosis codes in the French health insurance database to identify incident cases of lymphomas according to results of a regional cancer registry, as the gold standard.Between 2010 and 2013, incident lymphomas were identified in hospital data through 2 algorithms of selection. The results of the identification process and characteristics of incident lymphomas cases were compared with data from the Tarn Cancer Registry. Each algorithm's performance was assessed by estimating sensitivity, predictive positive value, specificity (SPE), and negative predictive value.During the period, the registry recorded 476 incident cases of lymphomas, of which 52 were Hodgkin lymphomas and 424 non-Hodgkin lymphomas. For corresponding area and period, algorithm 1 provides a number of incident cases close to the Registry, whereas algorithm 2 overestimated the number of incident cases by approximately 30%. Both algorithms were highly specific (SPE = 99.9%) but moderately sensitive. The comparative analysis illustrates that similar distribution and characteristics are observed in both sources.Given these findings, the use of claims database can be consider as a pertinent and powerful tool to conduct medico-economic or pharmacoepidemiological studies in lymphomas.

摘要

在实际情况下利用理赔数据库研究淋巴瘤是未来的一个关键问题。通过这种方式,开发用于在这些数据库中识别淋巴瘤的经过验证的算法至关重要。本研究的目的是根据作为金标准的地区癌症登记处的结果,评估法国健康保险数据库中诊断代码识别淋巴瘤新发病例的有效性。

在2010年至2013年期间,通过两种选择算法在医院数据中识别新发病例的淋巴瘤。将识别过程的结果和新发病例的淋巴瘤病例特征与塔恩癌症登记处的数据进行比较。通过估计敏感性、预测阳性值、特异性(SPE)和阴性预测值来评估每种算法的性能。

在此期间,登记处记录了476例淋巴瘤新发病例,其中52例为霍奇金淋巴瘤,424例为非霍奇金淋巴瘤。对于相应的地区和时期,算法1提供的新发病例数与登记处接近,而算法2高估了新发病例数约30%。两种算法都具有高度特异性(SPE = 99.9%)但敏感性中等。比较分析表明,两个来源中观察到相似的分布和特征。

鉴于这些发现,理赔数据库的使用可被视为在淋巴瘤中进行医学经济学或药物流行病学研究的相关且强大的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/498b/5943849/59f2905b2f4e/medi-97-e9418-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/498b/5943849/59f2905b2f4e/medi-97-e9418-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/498b/5943849/59f2905b2f4e/medi-97-e9418-g003.jpg

相似文献

1
A novel approach for medical research on lymphomas: A study validation of claims-based algorithms to identify incident cases.一种针对淋巴瘤医学研究的新方法:基于索赔算法识别新发病例的研究验证
Medicine (Baltimore). 2018 Jan;97(2):e9418. doi: 10.1097/MD.0000000000009418.
2
[Performance evaluation of hospital claims database for the identification of incident central nervous system tumors compared with a cancer registry in Gironde, France, 2004].[2004年法国吉伦特省医院理赔数据库用于识别中枢神经系统肿瘤发病情况与癌症登记处的性能评估]
Rev Epidemiol Sante Publique. 2012 Aug;60(4):295-304. doi: 10.1016/j.respe.2012.02.003. Epub 2012 Jun 15.
3
A systematic review of validated methods for identifying lymphoma using administrative data.利用行政数据识别淋巴瘤的验证方法的系统评价。
Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:203-12. doi: 10.1002/pds.2315.
4
Validation of an Algorithm for Claims-based Incidence of Prostate Cancer.基于索赔的前列腺癌发病率算法验证。
Epidemiology. 2019 May;30(3):466-471. doi: 10.1097/EDE.0000000000001007.
5
An algorithm for identifying chronic kidney disease in the French national health insurance claims database.一种用于在法国国家健康保险索赔数据库中识别慢性肾脏病的算法。
Nephrol Ther. 2022 Jul;18(4):255-262. doi: 10.1016/j.nephro.2022.03.003. Epub 2022 Jun 27.
6
The Design and Validation of a New Algorithm to Identify Incident Fractures in Administrative Claims Data.一种用于在行政索赔数据中识别骨折事件的新算法的设计与验证。
J Bone Miner Res. 2019 Oct;34(10):1798-1807. doi: 10.1002/jbmr.3807. Epub 2019 Aug 5.
7
Implementation of an algorithm for the identification of breast cancer deaths in German health insurance claims data: a validation study based on a record linkage with administrative mortality data.德国医疗保险理赔数据中乳腺癌死亡识别算法的实施:基于与行政死亡数据记录链接的验证研究
BMJ Open. 2019 Jul 26;9(7):e026834. doi: 10.1136/bmjopen-2018-026834.
8
Nationwide validation study of diagnostic algorithms for inflammatory bowel disease in Korean National Health Insurance Service database.韩国国家健康保险服务数据库中炎症性肠病诊断算法的全国验证研究。
J Gastroenterol Hepatol. 2020 May;35(5):760-768. doi: 10.1111/jgh.14855. Epub 2019 Oct 27.
9
[Role of hospital claims databases from care units for estimating thyroid cancer incidence in the Rhône-Alpes region of France].[法国罗纳-阿尔卑斯地区护理单位医院理赔数据库在估算甲状腺癌发病率方面的作用]
Rev Epidemiol Sante Publique. 2006 Oct;54(5):391-8. doi: 10.1016/s0398-7620(06)76737-2.
10
Validity of claims-based algorithms for selected cancers in Japan: Results from the VALIDATE-J study.基于日本特定癌症的索赔算法的有效性:VALIDATE-J 研究的结果。
Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1153-1161. doi: 10.1002/pds.5263. Epub 2021 Jun 1.

引用本文的文献

1
Validity of claims-based algorithms for selected cancers in Japan: Results from the VALIDATE-J study.基于日本特定癌症的索赔算法的有效性:VALIDATE-J 研究的结果。
Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1153-1161. doi: 10.1002/pds.5263. Epub 2021 Jun 1.

本文引用的文献

1
Identifying cancer drug regimens in French health insurance database: An application in multiple myeloma patients.在法国医疗保险数据库中识别癌症药物治疗方案:多发性骨髓瘤患者的应用。
Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1492-1499. doi: 10.1002/pds.4266. Epub 2017 Jul 25.
2
Evaluation of algorithms to identify incident cancer cases by using French health administrative databases.利用法国卫生行政数据库评估识别新发癌症病例的算法。
Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):935-944. doi: 10.1002/pds.4225. Epub 2017 May 9.
3
Identifying multiple myeloma patients using data from the French health insurance databases: Validation using a cancer registry.
利用法国健康保险数据库的数据识别多发性骨髓瘤患者:使用癌症登记处进行验证
Medicine (Baltimore). 2017 Mar;96(12):e6189. doi: 10.1097/MD.0000000000006189.
4
Novel agents versus chemotherapy as frontline treatment of CLL.新型药物与化疗作为慢性淋巴细胞白血病的一线治疗方法
Leuk Lymphoma. 2017 Jun;58(6):1320-1324. doi: 10.1080/10428194.2017.1280606. Epub 2017 Feb 6.
5
Helping everyone do better: a call for validation studies of routinely recorded health data.助力人人表现更佳:呼吁对常规记录的健康数据进行验证研究。
Clin Epidemiol. 2016 Apr 12;8:49-51. doi: 10.2147/CLEP.S104448. eCollection 2016.
6
The Emerging Role of PI3K Inhibitors in the Treatment of Hematological Malignancies: Preclinical Data and Clinical Progress to Date.PI3K 抑制剂在血液系统恶性肿瘤治疗中的新作用:目前的临床前数据和临床进展。
Drugs. 2016 Apr;76(6):639-46. doi: 10.1007/s40265-016-0565-4.
7
Molecular subtyping of diffuse large B-cell lymphoma: update on biology, diagnosis and emerging platforms for practising pathologists.弥漫性大B细胞淋巴瘤的分子亚型分类:病理医生的生物学、诊断及新兴平台的最新进展
Pathology. 2016 Jan;48(1):5-16. doi: 10.1016/j.pathol.2015.11.017. Epub 2015 Dec 17.
8
Validation of immune thrombocytopenia diagnosis code in the French hospital electronic database.法国医院电子数据库中免疫性血小板减少症诊断编码的验证
Eur J Intern Med. 2016 Jul;32:e21-2. doi: 10.1016/j.ejim.2016.02.021. Epub 2016 Mar 21.
9
The 2016 revision of the World Health Organization classification of lymphoid neoplasms.《世界卫生组织淋巴组织肿瘤分类(2016年修订版)》
Blood. 2016 May 19;127(20):2375-90. doi: 10.1182/blood-2016-01-643569. Epub 2016 Mar 15.
10
Cancer incidence in France over the 1980-2012 period: Hematological malignancies.1980 - 2012年期间法国的癌症发病率:血液系统恶性肿瘤
Rev Epidemiol Sante Publique. 2016 Apr;64(2):103-12. doi: 10.1016/j.respe.2015.12.017. Epub 2016 Mar 10.